Allahabad HC: Employees of Constituent Institutions are not Entitled to Central University Benefits  ||  Calcutta High Court: Juvenile Accused Eligible to Apply for Anticipatory Bail under Section 438 CrPC  ||  J&K & L HC: Departmental Proceedings Not Halted by Pending Criminal Case Without Showing Prejudice  ||  Cal HC: CESTAT Appeals Abate After Resolution Plan Success; CENVAT Reversal Requires No Pre-Deposit  ||  Bom HC: SEBI Settlement Doesn’t Protect Accused from Criminal Liability in Serious Economic Offences  ||  SC Directs States to Notify Eco-Sensitive Zones Around Tiger Reserves and Regulate Tiger Safaris  ||  SC: Its 2024 Order Letting Union Review Benami Act Cases Based on 'Ganpati Dealcom' was Incorrect  ||  SC: Rejection of Income Tax Settlement Application Doesn’t Bar Assessee from Contesting Assessment  ||  SC Informed Accessibility Facilities for Visually Impaired Candidates in AIBE and CLAT Expected Soon  ||  Supreme Court: Pendency of Writ Proceedings Does Not Bar Availing Alternative Statutory Remedies    

Kerala HC to Centre: Consider Compulsory Licensing of Drug Ribociclib - (22 Jun 2022)

INTELLECTUAL PROPERTY RIGHTS

Kerala High Court has directed the Department for Promotion of Industry and Internal Trade to consider compulsory licensing of Ribociclib, a breast cancer drug, considering the alarming number of women who succumb to the disease merely because they could not afford treatment.

Tags : KERALA HIGH COURT   COMPULSORY LICENSING   BREAST CANCER  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved